I think that is because it looks like the ADO technology is now being used in POC covid tests sold by Ellume to the US and it looks like it'll be only days/weeks before ADO's own tests will be validated and approved by TGA/FDA. The same technology can be used in a rapid 15min sepsis test. expectation is that it'll be ready by the end of this year. And that is very exciting. It is a test, not a cure but a valuable instrument to positively diagnose sepsis and give patients a better chance of survival. RCE hasn't started phase 1 trials yet. Not a single human. wing has been injected straight into the bloodstream with the magic RCE potion. it may work a miracle, it may kill the patient and everything in. between. Assuming all goes well we still have several years to go before any RCE component will become an approved sepsis treatment. Worth the gamble and the wait I think, but in the meantime the ADO sepsis test is potentially a life saver for many, hence the (moderate) current hype. Just my take on your question. I'm comfortable with holding a decent package in both companies.
RCE Price at posting:
$1.05 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)